Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated

Related Experiment Video

Updated: Aug 10, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Gibanananda Ray1, Gopal Dhar, Peter J Van Veldhuizen

  • 1Cancer Research Unit, Veterans Affairs Medical Center, Kansas City, Missouri, USA.

Biochemistry
|March 15, 2006
PubMed

Insights

2-Methoxyestradiol (2-ME(2)) is a potential anticancer drug that halts prostate cancer cell growth and triggers apoptosis. It impacts the cell cycle by increasing S and G2/M phases, mediated by MAPK-ERK-JNK signaling pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • 2-Methoxyestradiol (2-ME(2)) is an endogenous estrogen metabolite with demonstrated anticancer properties.
  • Prostate cancer cell lines, including androgen-dependent (LNCaP) and -independent (DU145, PC-3) types, are sensitive to 2-ME(2).
  • The precise mechanisms by which 2-ME(2) affects the cell cycle and induces apoptosis require further elucidation.

Purpose of the Study:

  • To investigate the dual impact of 2-ME(2) on the prostate cancer cell division cycle.
  • To identify the molecular pathways and regulatory networks involved in 2-ME(2)-induced growth arrest and apoptosis.
  • To explore the role of cyclin B1, cdc2 phosphorylation, and associated signaling pathways in 2-ME(2) action.

Main Methods:

  • Utilized flow cytometry to analyze cell cycle distribution after 2-ME(2) treatment.
  • Examined the expression and phosphorylation status of key cell cycle regulatory proteins, including cyclin B1, cdc2, wee1, and cdc25C.
  • Employed specific inhibitors for extracellular receptor kinase (ERK) and c-Jun N-terminal kinase (JNK) pathways (U0126 and SP600125, respectively) to probe signaling mechanisms.

Main Results:

  • 2-ME(2) treatment led to significant accumulation of cells in the S and G2/M phases, with a reduction in the G1 phase.
  • Overexpression of cyclin B1 and increased phosphorylation of cdc2, wee1, and phospho-cdc25C were observed.
  • Inhibition of ERK and JNK pathways abolished 2-ME(2)-induced cdc2 phosphorylation and wee1 upregulation.
  • These findings suggest a correlation between 2-ME(2)-induced apoptosis, G2/M arrest, S phase accumulation, and the modulation of specific cell cycle proteins.

Conclusions:

  • 2-Methoxyestradiol exerts a dual effect on the prostate cancer cell cycle, promoting S and G2/M phase arrest.
  • The anticancer effects of 2-ME(2) are linked to the modulation of cyclin B1, cdc2 phosphorylation, and related regulatory proteins.
  • The mitogen-activated protein kinase (MAPK) signaling pathway, specifically ERK and JNK, mediates the 2-ME(2)-induced upregulation of wee1 and subsequent cdc2 phosphorylation.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.